Cargando…
Mast cells in pancreatic ductal adenocarcinoma
Using in vivo models of pancreatic ductal adenocarcinoma (PDAC), we demonstrated that mast cells migrate to the tumor site and provide a microenvironment that allows for tumor progression. These results indicate that targeting mast cells may be a promising novel therapy for PDAC.
Autor principal: | Chang, David Z. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429584/ https://www.ncbi.nlm.nih.gov/pubmed/22934272 http://dx.doi.org/10.4161/onci.19612 |
Ejemplares similares
-
Macrophage-based immunotherapy for the treatment of pancreatic ductal adenocarcinoma
por: Beatty, Gregory L
Publicado: (2013) -
Engineered chimeric antigen receptor-expressing T cells for the treatment of pancreatic ductal adenocarcinoma
por: Beatty, Gregory L
Publicado: (2014) -
Intratumoral mast cells promote the growth of pancreatic cancer
por: Ma, Ying, et al.
Publicado: (2013) -
Macrophages increase the resistance of pancreatic adenocarcinoma cells to gemcitabine by upregulating cytidine deaminase
por: Amit, Moran, et al.
Publicado: (2013) -
SIN3B, the SASP, and pancreatic cancer
por: Cantor, David J, et al.
Publicado: (2014)